Freshfields’ Litigation Team successfully represented Sumitovant Biopharma Limited. A shareholder’s attempt to challenge a $2.9 billion take-private merger between Sumitovant Biopharma Limited (Sumitovant, formerly known as...
Zappia v. Myovant Sciences Ltd., et al.
Sumitovant’s Acquisition of Myovant Sciences
Sullivan & Cromwell advised Sumitovant and Sumitomo Pharma. Skadden served as legal counsel to the Special Committee of Myovant’s Independent Directors in connection with the transaction....